← Leaderboards
Jun Yan
University Of Louisville
$16,605,525
Attributed
$24,515,721
Total exposure
20
Grants
16
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $6.9M · FY2006–25$10M$7.5M$5M$2.5M$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$47,479,815 · 22
By mechanism
P20$22,482,971 · 7
P01$12,933,613 · 6
R01$11,452,206 · 7
R21$611,025 · 2
Top collaborators
- Teresa W-M Fan30 shared
- Andrew N Lane15 shared
- Jason A Chesney12 shared
- Jiapeng Huang7 shared
- Silvia M Uriarte7 shared
- Richard M Higashi5 shared
- Haixun Guo2 shared
Most similar at University Of Louisville
Same institution · by research overlap
- Jason A Chesney$5,360,168
- Craig J McClain$36,863,296
- David S. K. Magnuson$6,325,664
- Simon Michael Danner$2,784,184
- Aruni Bhatnagar Bhatnagar$35,834,843
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsResponseCellsTumorNovel StrategiesImmuneMediatingBaseCollaborationsMolecularEarly DiagnosisCessation Of LifeMacrophageNon-Small-Cell Lung CarcinomaCancer CellCytokineOutcome ForecastPathway InteractionsProgramsLinkT-LymphocyteLungAntibodiesInnovation
Grant awards (83)
Center for Cancer Immunology and Immunotherapy (CCII)$2,349,699
P20 · FY2025 · GM · contact PI
Center for Cancer Immunology and Immunotherapy (CCII) - Admin Core$910,398
P20 · FY2025 · GM · contact PI
Low Density Neutrophils Link Inflammation and Coagulopathy in COVID-19$720,048
R01 · FY2025 · HL · contact PI
Understanding Pancreatic Cancer Immune Microenvironment and Treatment Response through Integrating in vivo Imaging with Immunophenotyping$649,473
R01 · FY2025 · CA · contact PI
Neutrophil Heterogeneity and Immunopathogenesis of COVID-19 ARDS$556,881
R01 · FY2025 · AI · contact PI
Center for Cancer Immunology and Immunotherapy (CCII)$2,292,575
P20 · FY2024 · GM · contact PI
Administrative Core$947,067
P20 · FY2024 · GM · contact PI
Center for Cancer Immunology and Immunotherapy (CCII).$947,067
P20 · FY2024 · GM · contact PI
Low Density Neutrophils Link Inflammation and Coagulopathy in COVID-19$705,648
R01 · FY2024 · HL · contact PI
Understanding Pancreatic Cancer Immune Microenvironment and Treatment Response through Integrating in vivo Imaging with Immunophenotyping$649,473
R01 · FY2024 · CA · contact PI
Administrative Core$590,179
P20 · FY2024 · GM · contact PI
Neutrophil Heterogeneity and Immunopathogenesis of COVID-19 ARDS$574,104
R01 · FY2024 · AI · contact PI
TBD$217,147
P20 · FY2024 · GM · contact PI
Center for Cancer Immunology and Immunotherapy (CCII)$2,305,905
P20 · FY2023 · GM · contact PI
Low Density Neutrophils Link Inflammation and Coagulopathy in COVID-19$761,423
R01 · FY2023 · HL · contact PI
Administrative Core$685,965
P20 · FY2023 · GM · contact PI
Neutrophil Heterogeneity and Immunopathogenesis of COVID-19 ARDS$574,104
R01 · FY2023 · AI · contact PI
Center for Cancer Immunology and Immunotherapy (CCII)$260,726
P20 · FY2023 · GM · contact PI
TBD$248,337
P20 · FY2023 · GM · contact PI
TBD$235,580
P20 · FY2023 · GM · contact PI
Center for Cancer Immunology and Immunotherapy (CCII)$2,316,025
P20 · FY2022 · GM · contact PI
Low Density Neutrophils Link Inflammation and Coagulopathy in COVID-19$761,423
R01 · FY2022 · HL · contact PI
Administrative Core$735,549
P20 · FY2022 · GM · contact PI
Surveillance and identification of variants of concern within circulating SARS-CoV-2 across Kentucky$521,245
P20 · FY2022 · GM · contact PI
Center for Cancer Immunology and Immunotherapy (CCII)$2,324,733
P20 · FY2021 · GM · contact PI
Surveillance and identification of variants of concern within circulating SARS-CoV-2 across Kentucky$778,440
P20 · FY2021 · GM · contact PI
Administrative Core$737,703
P20 · FY2021 · GM · contact PI
Transcriptional Regulation of Immunosuppressive Macrophages by c-Maf in Cancer$352,275
R01 · FY2021 · CA · contact PI
Regulation of dermal gammadelta T cells by microbial pathogens/commensals in health and psoriasis$189,495
R01 · FY2021 · AI · contact PI
Center for Cancer Immunology and Immunotherapy (CCII)$2,337,631
P20 · FY2020 · GM · contact PI
Administrative Core$741,000
P20 · FY2020 · GM · contact PI
Transcriptional Regulation of Immunosuppressive Macrophages by c-Maf in Cancer$352,275
R01 · FY2020 · CA · contact PI
Regulation of dermal gammadelta T cells by microbial pathogens/commensals in health and psoriasis$192,238
R01 · FY2020 · AI · contact PI
Transcriptional Regulation of Immunosuppressive Macrophages by c-Maf in Cancer$341,706
R01 · FY2019 · CA · contact PI
Regulation of dermal gammadelta T cells by microbial pathogens/commensals in health and psoriasis$194,902
R01 · FY2019 · AI · contact PI
Transcriptional Regulation of Immunosuppressive Macrophages by c-Maf in Cancer$352,275
R01 · FY2018 · CA · contact PI
Regulation of dermal gammadelta T cells by microbial pathogens/commensals in health and psoriasis$197,488
R01 · FY2018 · AI · contact PI
Systems Biochemistry in Lung Cancer: Toward a Mechanistic Understanding of NSCLC$1,264,894
P01 · FY2017 · CA
Transcriptional Regulation of Immunosuppressive Macrophages by c-Maf in Cancer$352,275
R01 · FY2017 · CA · contact PI
Stable Isotope Resolved Metabolomics Analytical Shared Core$284,058
P01 · FY2017 · CA
Microenvironmental Nutrient Availability and Immunomodulation in Lung Cancer Cells: A systems biochemical approach$251,655
P01 · FY2017 · CA
Determining Tumor Metabolism and Biochemical Mechanism of beta-glucan Action in$240,785
P01 · FY2017 · CA · contact PI
Determining Molecular Mechanisms of NSCLC and Response to beta-glucan$236,598
P01 · FY2017 · CA
Regulation of dermal gammadelta T cells by microbial pathogens/commensals in health and psoriasis$200,000
R01 · FY2017 · AI · contact PI
Administration, Bioinformatics and Biostatistics Core$125,308
P01 · FY2017 · CA
Regulation of GC B Cells by Transcription Factor STAT3$115,500
R21 · FY2017 · AI · contact PI
Systems Biochemistry in Lung Cancer: Toward a Mechanistic Understanding of NSCLC$1,337,134
P01 · FY2016 · CA
Stable Isotope Resolved Metabolomics Analytical Shared Core$330,070
P01 · FY2016 · CA
Microenvironmental Nutrient Availability and Immunomodulation in Lung Cancer Cells: A systems biochemical approach$294,066
P01 · FY2016 · CA
Determining Tumor Metabolism and Biochemical Mechanism of beta-glucan Action in$281,989
P01 · FY2016 · CA · contact PI
Determining Molecular Mechanisms of NSCLC and Response to beta-glucan$277,335
P01 · FY2016 · CA
Role of STAT3 Signaling in GC B Cell Regulation$229,074
R21 · FY2016 · AI · contact PI
Administration, Bioinformatics and Biostatistics Core$153,681
P01 · FY2016 · CA
Regulation of GC B Cells by Transcription Factor STAT3$76,834
R21 · FY2016 · AI · contact PI
Systems Biochemistry in Lung Cancer: Toward a Mechanistic Understanding of NSCLC$1,263,861
P01 · FY2015 · CA
Stable Isotope Resolved Metabolomics Analytical Shared Core$315,363
P01 · FY2015 · CA
Microenvironmental Nutrient Availability and Immunomodulation in Lung Cancer Cel$279,388
P01 · FY2015 · CA
Determining Tumor Metabolism and Biochemical Mechanism of beta-glucan Action in$267,320
P01 · FY2015 · CA · contact PI
Determining Molecular Mechanisms of NSCLC and Response to beta-glucan$262,672
P01 · FY2015 · CA
Role of STAT3 Signaling in GC B Cell Regulation$189,617
R21 · FY2015 · AI · contact PI
Administration, Bioinformatics and Biostatistics Core$139,118
P01 · FY2015 · CA
Systems Biochemistry in Lung Cancer: Toward a Mechanistic Understanding of NSCLC$1,236,441
P01 · FY2014 · CA
Stable Isotope Resolved Metabolomics Analytical Shared Core$308,521
P01 · FY2014 · CA
Microenvironmental Nutrient Availability and Immunomodulation in Lung Cancer Cel$273,326
P01 · FY2014 · CA
Determining Tumor Metabolism and Biochemical Mechanism of beta-glucan Action in$261,521
P01 · FY2014 · CA · contact PI
Determining Molecular Mechanisms of NSCLC and Response to beta-glucan$256,974
P01 · FY2014 · CA
Administration, Bioinformatics and Biostatistics Core$136,099
P01 · FY2014 · CA
Systems Biochemistry in Lung Cancer: Toward a Mechanistic Understanding of NSCLC$1,427,718
P01 · FY2013 · CA
Stable Isotope Resolved Metabolomics Analytical Shared Core$356,250
P01 · FY2013 · CA
Microenvironmental Nutrient Availability and Immunomodulation in Lung Cancer Cel$315,609
P01 · FY2013 · CA
Determining Tumor Metabolism and Biochemical Mechanism of beta-glucan Action in$301,977
P01 · FY2013 · CA · contact PI
Determining Molecular Mechanisms of NSCLC and Response to beta-glucan$296,727
P01 · FY2013 · CA
Administration, Bioinformatics and Biostatistics Core$157,155
P01 · FY2013 · CA
Mechanisms of Immune Modulation Mediated by Yeast-derived Particulate Beta-Glucan$358,900
R01 · FY2012 · CA · contact PI
Mechanisms of Immune Modulation Mediated by Yeast-derived Particulate Beta-Glucan$358,900
R01 · FY2011 · CA · contact PI
Mechanisms of Immune Modulation Mediated by Yeast-derived Particulate Beta-Glucan$370,000
R01 · FY2010 · CA · contact PI
Mechanisms of Immune Modulation Mediated by Yeast-derived Particulate Beta-Glucan$370,000
R01 · FY2009 · CA · contact PI
Ligation of CR3 by Glucan and iC3b Links Innate and Adaptive Anti-tumor Immunity$253,501
R01 · FY2009 · CA · contact PI
Ligation of CR3 by Glucan and iC3b Links Innate and Adaptive Anti-tumor Immunity$253,501
R01 · FY2008 · CA · contact PI
Ligation of CR3 by Glucan and iC3b Links Innate and Adaptive Anti-tumor Immunity$253,501
R01 · FY2007 · CA · contact PI
Ligation of CR3 by Glucan and iC3b Links Innate and Adaptive Anti-tumor Immunity$230,597
R01 · FY2006 · CA · contact PI
TARGETING OF PHAGOCYTE & NK CELL CR3 TO TUMOR-BOUND IC3B$66,600
R01 · FY2006 · CA · contact PI
TARGETING OF PHAGOCYTE &NK CELL CR3 TO TUMOR-BOUND IC3B$259,200
R01 · FY2004 · CA